Replies to post #3228 on Marker Therapeutics Inc (MRKR)

[chrisgold]

It has long way to go till it gets a FDA approval ....they need to do lot of financing and we can expect more dilution over the next few years for their clinical trials.....there is no other way than further dilution.....several of their competitors are well ahead in the clinical trials gnbt , gale etc.....so it's difficult for tpiv.....and we may see this below 1 cent soon ....jmy 2 cents glta